The GCTF-PRO seeks to examine the extent gastric cancer patients are tapping into new information particularly outside of conventional healthcare disclosures. Its significance is in assessing dimensions of QOL paradigms that frame statistical power using predictive methods. It seeks to embed evidence-based theories (perceptual and cognitive) to awareness levels in an attempt to bridge the biotechnological advances with prognostic/ diagnostic-related patient satisfactions. At present, it may complement existing GC QOL instruments and offer a novel approach on how cellular level prognoses could possibly correlate with QOL measures.
semantic differential rating (ordinal) scale with a series of polar opposites. The patient rates each treating professional or medium (internet) -the second construct (appendix B). This domain measures the areas of trust a patient has on transcription factors and is scaled by comparing estimates. At present, the raw data I gleaned from the literature (2013 --2014) contains 247 items for domains 1 and 3; domain 2 has 32 items; domain 4 has 11 items; domain 5 has 30 items. In total there are 320 items. The recall period is dependant on disease progression and staging. The survival rate for advanced GC stages III and IV range from 2 weeks, 6 months to 2 years or more. GC is often detected in the latter stages III and IV. Treatment plans (chemotherapy, radiotherapy and/or surgery) are devised usually within a month from diagnosis. Hence the optimal time period for completing the questionnaire may depend on the optimal time period for recalling transcription factors after diagnosis and during the disease progression. The focus groups and pre--screen selection criteria may help determine an optimal time parameter for administering the questionnaire. Level of awareness on transcription factors; summing known items (construct 1).
DIAGNOSIS

32
Nominal Level of awareness on cellular level prognoses; summing known items (construct 1).
DIMENSIONS OF CARE
247 combined with domain 1
Nominal (potential ordinal)
Level of awareness on transcription factors; summing known items (construct 1).
TREATMENT
11
Nominal (potential ordinal)
PERCEPTIONS
Ordinal
Areas of trust on transcription factors from scaled comparisons (construct 2).
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The purpose of GCTF--PRO is to complement existing PRO instruments measuring QOL in GC patients: EORTC QLQ--C30, EORTC QLQ--STO22, FACT--G, FACT--Ga, MDASI--GI (Xu et al., 2013; Khanna et al., 2014) , and systematically assess whether exposure to potentially undisclosed information such as transcription factors, influence a patient's sense of wellbeing. It may be argued -information empowers. A more informed patient -no matter how intricate the information -is a happier patient. On the other hand, information overload or intangible, idiosyncratic information -may harm a patient. With advancing technologies e.g.
recombinant DNA and new therapies involving genetic amalgamations, the patient may be more exposed to these elements, and are increasingly attuned to these potentials (Gotay et. al 2008 (Gotay et. al , p. 1361 . For advanced gastric patients, palliative treatment plans offer little hope.
So much of the literature today, report cutting--edge, gene--driven frontiers and the information is readily available on the Internet. Do any parts of these published findings offer hopeful incentives? Do they affect a patient's QOL? The GCTF--PRO attempts to explore if such exposures affect a patient's QOL. Ideally, it will eventually be a QOL instrument with latent variables rooted in perceptual and cognitive theories, modelled with heuristics mapped to QOL factors -rather than remaining a questionnaire measuring attitudes towards transcription factors. However, there is an overall decline in searching for traditional cancer related treatments. Trials and cancer related gene therapies did not yield a significant trend. The database may lack sensitivity and specificity. However, broad interests in transcription factors i.e. 'Genes,'
PROM's purpose
'DNA,' can be noted. This is not to imply a surging interest in gene therapies in gastric cancer patients, but a potential awareness and interest in transcription factors overall in the worldwide general population. Sensitive and specific search terms taken from search engine databases could provide insights into which transcription factors impact the general public. This may not be specific to GC patients, but could nevertheless be validated in this population. The information is then cross--matched to impact factors (H--index) on specific transcription factors, ranked and pooled and verified among experts. Some transcription terms may not be evidence--based.
Focus groups may generate novel items intrinsic to QOL. For example, Santa Claus and presents is a more likely association, than a furry robed stranger climbing down your chimney, raiding your fridge, gobbling up your cookies and leaving a sooty mess. Santa is easily identifiable like a transcription term, but associations beyond that is usually beyond 
Item selection method
The literature search for domains 1 and 3: I read the abstracts in each article and selected each acronym with a transcription reference. I looked up each term online to ensure each item was related to transcription factors. Domain 2 and 4: I eyeballed and selected terms from reviews and GC PROMs on prognoses, diagnoses, trials and treatments (appendix A). In algorithm sequencings: item selection is anticipated to come from frequency distributions of transcription related terms. However, it would be difficult to filter for GC patients. In focus groups: letter primes and cognitive--based tasks may help facilitate item rank and selection.
Transcripts from focus groups and expert opinions could undergo qualitative analysis such as grounding, so that key word selections directly or indirectly associated with transcription factors reflect latent variables intrinsic to a proposed theory.
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Aggregation Domains 1 and 3 consist of 247 items presented concurrently. The resulting score is aggregated to domain 2 consisting of 32 items and domain 4 with 11 items. Domain 5 is a separate construct to the other domains and when completed total 30 items. The total single score possible is 320 (appendix A & B). Items should be pooled and categorised
proper after input adjustments from focus groups, expert opinions and algorithm sequencings. The domain scores are compared using multifactorial analysis methods. This PROM is novel -the cut--off thresholds at present, have little a priori basis to be set at certain levels that detect awareness and confidences in trust. Hence in the early stages, observing summary scales between--patients could help direct methods that employ appropriate and effective aggregation strategies.
Instruction comprehensibility
The instructions should be clear from the questionnaire's onset. There is a possibility when unblind, the study's true intention may prompt biased responses. This will require further investigation during the questionnaire's design phase. A general definition of transcription factors prior to administering the questionnaire may ensure the task does not overwhelm participants. Instruction pitfalls to avoid will include ensuring the questions are not ambiguous; double--barrelled, jargon left from item generation and selection, value--laden;
worded both positive and negative. Pilot runs and software programs could assist appropriate wording, and selection criteria more sensitive so that the instructions do not confound and bias the outcome.
Given the complexity in transcription terms, numerous content revisions are anticipated so that the items are translatable. Even if the items themselves cover the construct of interest, whether this comprehensibility translates to an exact recall is doubtful. The focus groups and cognition--based heuristics may facilitate some of these anticipated challenges. Recall triggers within letter strings, modifying presentations into meaningful groups, transcription factors embedded in vignette scenarios and so on, are mechanisms that could assist translatability. Sampling issues: Age--related factors may also influence translatability. For instance, are younger age brackets more prone to fluent recall, thus elevates QOL? Recalling transcription terms may not even be a true reflection of 'awareness' and 'trust.' Packaging transcription terms into observable treatment outcomes may in fact show the true effect, as opposed to a theory--based design. Such disparate issues should be discerned when collecting data from focus groups, expert opinions and when sequencing algorithms.
Layout and format
Items on scales should not be worded too long or too short. Holden et al. (1985) found on average, items containing 10 to 20 characters had validity coefficients four times higher than items containing 70 to 80 letters and a load on working memory (Streiner & Norman 2003, p. 82) . Item characteristics are an important component to this PROM, and are anticipated attributes in latent variables, hence items should be laid out clearly: such as complex letter strings packaged in evidence--based digestible formats, and tried and tested layouts. It should mimic the preferred layout and format in a GC population -subject to feedback, and analysed for statistical consistency. It has the potential to yield low content validity and is therefore at present, assigned a full score upon completing the questionnaire.
Face validity
The items on the surface need to appear to measure what it purports to measure. That way, at face value, it is easy to see the nature and purpose of this instrument. This PROM seeks to complement existing GC QOL instruments, to make easy administration and scoring, so that researchers and policy makers can more readily adopt it. Patients could also rate the questionnaire on a 5--point scale (extremely suitable to irrelevant) so that offensive superficial particulars can be re--formatted.
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Criterion validity
There appears to be no gold standard for measuring an awareness or trust of transcription 
Construct validity
The most concern to construct validity is ensuring the content (transcription terms) is 
Measurement error
At present, the main concern is item translation. Presenting a questionnaire with a list of acronyms may not measure anything at all -hence a tendency in responses to commit non--differential errors and bias the outcome towards the null. No validation, consistency and evidence of agreement in self--reports i.e. failed re--tests or lack of internal consistency, may lead to various measurement errors: inconsistent (numerical) variable responses in the same item within--patients, or inconsistent variable extents between--patients on the true underlying trait. The exposure is also uncontrolled and screened prior, so there could be recall biases leading to differential misclassification errors and bias towards or away from the null. Initial systematic errors are anticipated due to item complexity -all patients may find the items unintelligible--causing bias. Random errors may also arise from inconsistent variable exposures, personal issues, aptitude levels and other unmeasurable pre--screen selection factors -leading to more inconsistent variability in measurements without a recognisable pattern.
Test--retest reliability
In this PROM, conducting two tests in the same sample is not feasible, and may inflate or deflate intra--individual variability. Exposure to the items first time round makes it more likely the patient recognises the items second time round. Split--half reliability tests may be more feasible. At present, latent variables remain undefined in a psychosocial construct:
level of awareness and areas of trust. However, it is anticipated, theory--based criteria may determine re--test variation extents within and between--patients: scores on tests re--adjusted and scaled relative to an a priori estimate criteria within a Bayesian effect model.
Internal consistency
Ideally, Cronbach's alpha should be between 0.8--0.9. Factor analysis (when items are grouped and constructed into meaningful chunks) can help eliminate and group items based on correlations. Different aspects of the same construct can also be revealed through item loadings. For instance, highly popularised or memorable transcription terms are anticipated to yield consistent variance, whereas obscure terms may not add much meaningful value to the outcome because it yields no consistent variance. At present, based on nominal scales in which items are either identified or not -Kuder Richardson Formula 20 could test for correlations and provide a psychometric quality to individual items which can facilitate the removal of certain items and contribute to theory--driven directions.
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Reducing error methods
Focus groups, expert opinions and algorithm sequencings may better package items into meaningful chunks, groups or vignettes based on perception and cognition theories. This features often in the media. These decision options could be mapped using normative or behavioural models i.e. perceptual and cognitive findings. The below maps an example with the transcription factor SOX2 in a population screened with the exposure (dummy results):
SOX2
The relative values for each decision is weighed and assessed and measures cardinal preferences (standard gamble method). On the other hand, consumer choice methods (ordinal utility) might be more appropriate for measuring media appeal. Later on, utilities and classification systems in this PROM may include descriptions of transcription factors that extend across disease states in a QOL paradigm. For now, the type of utility measure adopted could complement existing instruments depending on who the party of interest is.
Clinical results implications
The clinical implications of cost--effective ratios in a cost--utility analysis may mean enacting policies in health parastatals that re--envision efficient and effective prognostic/ diagnostic methods. This may include communicating across transcription factors to GC patients using biotechnology devices. Health professionals may need to be re--trained on transcription factors pioneered in research industries, so that patients can ask questions confidently (Tzelepis et. al, 2014) . Influences from the media can also be made accountable when debunked and addressed by a health professional. A patient no longer needs to consider risks alone when consenting to a trial -if there are adequate support systems to ensure health professionals are communicating with research sectors and to a patient, this may improve long--term efficiency in treatment outcomes and to a patient's QOL.
Resource results implications
Monitoring and communicating across transcription factors require access to biotechnology information and devices. It may in fact be inevitable more and more people in the future will naturally gravitate towards knowing more about their genetic make up and other cellular level information. Research in this area is also rapidly expanding with intelligent technological advances. The results from cost--utility analyses on transcription factors may be more widely funded when it is arguably commensurate to consumer need. At present, cost--effectiveness as utility weights, measure artefacts on assessment processes shaped by theory--driven constructs but not the patient's real--world choices (Lenert & Kaplan 2000, p. II--139; See diagram below). Algorithm sequencings, expert opinions and focus groups, may not reflect real--world choices, particularly for this PROM because such preference systems for transcription factors do not yet exist. Hence it would be unreliable to conduct multiple regressions or descriptive analyses alone for calculating preference--based utility measures (Dobrez et al. 2007 ). However, a Bayesian approach for interpreting utility data could estimate the patient's utility before measurement. Researchers can then aggregate these measurements and form estimate mean utilities in populations and groups.
This approach can further be modelled to obtain a preference elicitation (Lenert & Kaplan 2000, p. II--141) .
Without going into detail, a preference elicitation framework for transcription factors may provide a broader platform to the processes concerning utility weights, and disseminate more openly on resource allocation policies.
Study question, hypotheses and outcomes
Answerable question in PICO format: à Can cellular localisation prognoses affect QOL in GC patients?
Hypothesis: "Awareness" of transcription factors affects QOL in GC patients.
: No association between transcription factors and QOL.
: "Awareness" of transcription factors affects QOL.
The study question examines whether exposure to cellular localisation prognoses affect the GC patient's sense of wellbeing or QOL (outcome).
Outcome measures, endpoints, frequency, assessment duration
Outcome measures
The outcome measure is based on whether exposure to transcription factors affects a patient's sense of wellbeing or QOL. Since this PROM seeks to complement existing instruments, the 'affect' is determined by the underlying latent variables embedded in the instrument: between those exposed to transcription factors and those who have not. The outcome measure (this PROM) aggregates a single score on transcription 'awareness levels'
(dichotomous scale; at present) and 'areas of trust' (semantic differential rating scale). 
Endpoints
At present, a higher score assumes a higher awareness level with a maximum score of 320.
A single endpoint is anticipated so the outcome is clearly defined and directly transferable.
Frequency
The PROM is administered once but it needs to be presented at a point in time when there is a general tendency for GC patients exposed to cellular level prognoses.
Assessment duration
The questionnaire is self--completed, at present it is uncertain how long the questionnaire will take to complete. It is however a one off assessment with no follow--up.
Repeated measures, missing values, multiple testing
The problem with repeated measures and multiple testing in this PROM -the exposure to the questionnaire may prime the patient to seek further transcription related information. 
Results presentation
The results should be presented succinct with accompanying flow diagrams. For example, a tree diagram with probable estimates. A summary of transcription terms -its impact factor, association and other algorithm sequencings could be categorised in a summary in respect to outcome. The analysis for each transcription term should be attached to the appendix so the proposed model can be replicated, distributed and updated by other researchers.
Disseminating the results will most likely entail publishing in a journal and conforming to guidelines: Labelled figures and tables, summary of the findings and presentations in line with the CONSORT statement, COCHRANE, APA or other standards depending on which study or review was used to validate and present the PROM.
Significance of proposed PROM
The GCTF--PRO seeks to examine the extent GC patients are tapping into new information particularly outside of conventional healthcare disclosures. Its significance is in assessing dimensions of QOL paradigms that frame statistical power using predictive methods. It seeks to embed evidence--based theories (perceptual and cognitive) to awareness levels in an attempt to bridge the biotechnological advances with prognostic/ diagnostic--related patient satisfactions. At present, it may complement existing GC QOL instruments and offer a novel proposal on how cellular level prognoses could possibly correlate with QOL.
Is the population developing a symbiosis with biotechnology? Should we be re--envisioning conventional treatment strategies i.e. dysfunctional multidisciplinary teams and paternalism despite "patient--centred" exteriors, to one where a patient is informed and can monitor their progress at a cellular level, and can truly make informed decisions about their treatment? These are practical problems this PROM alone cannot answer, but nevertheless seeks to raise social discourse on potential solutions. In terms of QOL, this PROM seeks to frame theories from existentialism -Sartre: Human beings cannot be fully questioned and understood with science or morals. "Authenticity" demonstrates a practical, embodied individual, true to one's personality and self. This is the "quality" and new knowledge the GCTF--PRO seeks to operationalise.
Results implication
The results will most likely have adopted predictive methods not normally applied in health research. This implies an emphasis on design and modelling before collecting data and conducting interviews in a manner that reflect the underlying theory. 
